LAB director buys 75,000 shares near 52-week low
Alpha Vantage · Investing.com Canada · · AI-summarised by FinFlash
Thomas D. Carey, a director at Standard BioTools Inc. (NASDAQ:LAB), recently purchased 75,000 shares of the company's common stock for $46,897 at a price of $0.6253 each. This transaction occurred on November 5, 2026, when the stock was trading near its 52-week low. Following this acquisition, Mr. Carey now directly holds 419,456 shares of Standard BioTools.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.